Canoui-Poitrine F, Revuz JE, Wolkenstein P et al. Clinical characteristics of a series of 302
French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009;61:51–7.
Collier F, Smith R, Morton C. Diagnosis and management of hidradenitis suppurativa. BMJ.2013;346:f2121.
Crowley JJ, Mekkes JR, Zouboulis CC et al. Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. Br J Dermatol 2014;171:1561–65. Fitzsimmons JS, Guilbert PR. A family study of hidradenitis suppurativa. J Med Genet 1985;22:367–73.
Hidradenitis Suppurativa Trust. Common Questions and Answers. Available at http://www.hstrust.org/qanda.html. Accessed May 2016.
Irish Skin Foundation. Suppurativa hydradenitis. HS FAQS (01 September 2015). Available at http://irishskinfoundation.ie/hs/hs-faqs/. Accessed May 2016.
Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366:158–64.
Kromann CB, Deckers IE, Esmann S et al. Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol 2014;171:819–24.
National Organisation for Rare Disease (NORD). Hidradenitis suppurativa. Available at http://rarediseases.org/rare-diseases/hidradenitis-suppurativa/. Accessed May 2016. Pink AE, Simpson MA, Desai N et al. Mutations in the gamma-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa). J Invest Dermatol 2012;132:2459–61.
Sartorius K, Emtestam L, Jemec GB et al. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009;161: 831–9. Schrader AM, Deckers IE, van der Zee HH et al. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 2014;71:460–7.
Sørensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg. 2012;147(4):373-83.
Vazquez BG, Alikhan A, Weaver AL et al. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol 2013;133:97–103.
Zouboulis CC, del Marmol V, Mrowietz U et al. Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 2015b;231:184–90.
Zouboulis CC, Desai N, Emtestam L et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015a;29:619–44.